Home LiteratureArticle Details
PMID: 7507188 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Characterization of mutants of human immunodeficiency virus type 1 that have escaped neutralization by a monoclonal antibody to the gp120 V2 loop.

Journal of virology ·Vol. 68 ·No. 2 ·1994-02-00 ·Pages 974-8

Yoshiyama H, Mo H, Moore JP, Ho DD

Abstract

The biologically cloned human immunodeficiency virus type 1 (HIV-1) RF isolate is sensitive to neutralization by the murine monoclonal antibody (MAb) G3-4 to a conformationally sensitive epitope in the V2 loop of HIV-1 gp120. To assess how variation in the V2 amino acid sequence affects neutralization by this MAb, we cultured RF in the presence of G3-4 to select neutralization escape mutants. Three such mutants resistant to G3-4 neutralization were generated from three independent experiments. Solubilized gp120 from each of these escape mutants had a reduced affinity for G3-4 and also for two other V2 MAbs that were able to bind the wild-type RF gp120. PCR sequencing of the entire gp120 of the wild-type RF virus and the escape mutants showed that amino acid substitutions had occurred only at two positions, Y177H and L179P, both in V2. Experimental introduction of the Y177H substitution into the RF V2 loop in the context of the NL4-3 molecular clone re-created the G3-4-resistant phenotype. The L179P mutant was not viable. Thus, our findings confirm that the HIV-1 V2 loop contains the conformationally sensitive neutralization epitope recognized by G3-4 and that a single amino acid substitution within this region can result in escape variants that arise from immune selection pressure.

MeSH Terms
Amino Acid Sequence Animals Antibodies, Monoclonal/immunology Base Sequence Cloning, Molecular Epitopes/genetics HIV Antibodies/immunology HIV Envelope Protein gp120/genetics,immunology HIV-1/genetics,immunology Mice Molecular Sequence Data Mutation Neutralization Tests Sequence Analysis, DNA Sequence Homology, Amino Acid
Chemicals
Antibodies, Monoclonal Epitopes HIV Antibodies HIV Envelope Protein gp120
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Yoshiyama H
Aaron Diamond AIDS Research Center, New York University School of Medicine, New York 10016.
Mo H
Moore J P
Ho D D
References (31)
31 references, click to expand
  1. Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region.
    J Immunol. 1990 Nov 15;145(10):3240-6 PMID: 1700002
  2. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.
    J Virol. 1990 Aug;64(8):3779-91 PMID: 2370681
  3. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3097-101 PMID: 2014229
  4. Generation of diversity in retroviruses.
    Annu Rev Genet. 1990;24:409-45 PMID: 1708222
  5. Neutralization of HIV-1: a paradox of humoral proportions.
    FASEB J. 1991 Jul;5(10):2437-55 PMID: 1712328
  6. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
    Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):8949-52 PMID: 1717992
  7. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.
    J Virol. 1992 Feb;66(2):848-56 PMID: 1370558
  8. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.
    AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51 PMID: 1380261
  9. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1992 Jun;8(6):1165-70 PMID: 1380263
  10. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence.
    Virology. 1992 Dec;191(2):837-45 PMID: 1448927
  11. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
    J Virol. 1993 May;67(5):2747-55 PMID: 8474172
  12. The role of the V3 loop of gp120 in HIV infection.
    AIDS. 1991;5 Suppl 2:S21-33 PMID: 1845049
  13. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.
    J Virol. 1993 Jun;67(6):3674-9 PMID: 8497077
  14. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
    J Virol. 1993 Jul;67(7):3978-88 PMID: 7685405
  15. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
    J Virol. 1993 Jul;67(7):4104-13 PMID: 8510218
  16. Biological cloning of functionally diverse quasispecies of HIV-1.
    AIDS Res Hum Retroviruses. 1993 Jun;9(6):541-6 PMID: 8347398
  17. Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.
    J Virol. 1993 Oct;67(10):6136-51 PMID: 7690418
  18. Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.
    J Virol. 1993 Nov;67(11):6897-902 PMID: 8411395
  19. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.
    J Virol. 1994 Jan;68(1):469-84 PMID: 7504741
  20. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.
    Science. 1985 May 31;228(4703):1091-4 PMID: 2986290
  21. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.
    Cell. 1986 Jun 6;45(5):637-48 PMID: 2423250
  22. Genetic variation in AIDS viruses.
    Cell. 1986 Jul 4;46(1):1-4 PMID: 3013415
  23. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
    J Virol. 1987 Feb;61(2):570-8 PMID: 2433466
  24. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.
    Cell. 1988 Jul 1;54(1):57-63 PMID: 2838179
  25. Differential neutralizing capacity to different human immunodeficiency virus (HIV) isolates by a rabbit antiserum against LAV: sensitive assays with HTLV-I-positive MT-4 cells.
    AIDS Res Hum Retroviruses. 1988 Apr;4(2):91-8 PMID: 3284555
  26. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients.
    Science. 1985 May 3;228(4699):593-5 PMID: 2984774
  27. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
    Nature. 1990 Jun 14;345(6276):622-5 PMID: 2190095
  28. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    AIDS. 1990 Apr;4(4):307-15 PMID: 2190605
  29. The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.
    J Virol. 1990 Jul;64(7):3240-8 PMID: 2352323
  30. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
    J Biol Chem. 1990 Jun 25;265(18):10373-82 PMID: 2355006
  31. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):542-6 PMID: 1988952
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-02-00
Pages
974-8
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC236535
Subset
IM
Grants
NIAID NIH HHS · AI24030 · United States
NIAID NIH HHS · AI25541 · United States
NIAID NIH HHS · AI27742 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]